Receive funding for your R&D Projects!
Your partner for subsidy advice
Your partner for subsidy advice
An international team led by researchers at the Broad Institute and Massachusetts General Hospital (MGH) has identified mutations in a gene that can reduce the…
A University of Houston (UH) scientist and his team are working to develop the next generation of prostate cancer therapies, which are targeted at metabolism.
This is an innovative application for life science industry. Furthermore, this application is a universal utility in screenings of drug efficiency e.g. against human-pathogenic microorganisms. It is also possible to test drugs against ion channel function of viruses or molecule libraries for selection of small molecules as new targets or for side effects.
The present development is a device that allows an incubation for specific areas, particularly for each individual vessel, providing these light/dark conditions and at the same time the implementation of optical measurements without interacting with experimental conditions in other areas
So-called extremely low-volatility organic compounds, which are produced by plants, could be detected for the first time during field and laboratory…
A bright supernova discovered only six weeks ago in a nearby galaxy is provoking new questions about the exploding stars that scientists use as their main…